GBM26 GBM Model

GBM26, a Patient-Derived Xenograft (PDX) model, is your key to unlocking brain cancer’s secrets. Use this model to investigate disease mechanisms and develop innovative therapies. PDX models like GBM26 play a critical role in preclinical drug discovery by providing a reliable platform for testing drug candidates. GBM26 closely mimics the patient’s tumor, allowing researchers to assess treatment efficacy and safety before advancing to clinical trials. By utilizing GBM26, you can accelerate the development of effective brain cancer treatments and enhance patient outcomes.

Model Details

Cancer Location: Intracranial
Cancer Type: Brain Cancer
Model Name: GBM26
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Temozolomide), Radiation (2Gy)
WES: Yes
RNAseq: Yes
Methylation: Yes
PDX Treatment: Yes
Patient Treatment History: Yes

GMB26 Survival

Survival of orthotopic intracranial implanted  GBM26 in Nu/Nu mice  (n=5)

Request Additional GBM Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content